Dosing and administration
Posology 1Adult plaque psoriasis The recommended dose is 300 mg of secukinumab by subcutaneous injection with initial dosing at weeks 0, 1, 2, 3 and 4, followed by monthly maintenance dosing. Based on clinical response...
Twitter Linkedin Facebook Pinterest Google plusReimbursement
In the documents below (NL and FR), an overview is given of the packs, prescriptions and paragraph number.
cosentyx_reimbursement.pngThe reimbursement documents can be found at the BCFI website
NL:...
Twitter Linkedin Facebook Pinterest Google plusMechanism of action
Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). 1 Cosentyx works by targeting IL-17A and inhibiting its interaction with...
Twitter Linkedin Facebook Pinterest Google plusPatient Resources
Spondyloarthritis (SpA)
Classification criteria
Therapeutic landscape
Useful links
Indications
Cosentyx is approved in 7 indications 1 :
Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy....
Twitter Linkedin Facebook Pinterest Google plus